Cardiff Lexington Past Earnings Performance
Past criteria checks 2/6
Cardiff Lexington has been growing earnings at an average annual rate of 42.8%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 31.7% per year. Cardiff Lexington's return on equity is 40.2%, and it has net margins of 19.7%.
Key information
42.8%
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 31.7% |
| Return on equity | 40.2% |
| Net Margin | 19.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cardiff Lexington makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 12 | 2 | 4 | 0 |
| 31 Dec 23 | 12 | 2 | 3 | 0 |
| 30 Sep 23 | 12 | -1 | 4 | 0 |
| 30 Jun 23 | 12 | -4 | 4 | 0 |
| 31 Mar 23 | 12 | -4 | 4 | 0 |
| 31 Dec 22 | 11 | -4 | 3 | 0 |
| 30 Sep 22 | 13 | 2 | 4 | 0 |
| 30 Jun 22 | 13 | 3 | 4 | 0 |
| 31 Mar 22 | 12 | 0 | 5 | 0 |
| 31 Dec 21 | 10 | 0 | 4 | 0 |
| 30 Sep 21 | 7 | -8 | 4 | 0 |
| 30 Jun 21 | 5 | -4 | 4 | 0 |
| 31 Mar 21 | 3 | -1 | 4 | 0 |
| 31 Dec 20 | 3 | -5 | 4 | 0 |
| 30 Sep 20 | 3 | 2 | 3 | 0 |
| 30 Jun 20 | 4 | -5 | 3 | 0 |
| 31 Mar 20 | 4 | -7 | 3 | 0 |
| 31 Dec 19 | 4 | -6 | 3 | 0 |
| 30 Sep 19 | 4 | -7 | 3 | 0 |
| 30 Jun 19 | 3 | -9 | 3 | 0 |
| 31 Mar 19 | 3 | -9 | 3 | 0 |
| 31 Dec 18 | 2 | -4 | 3 | 0 |
| 30 Sep 18 | 2 | -7 | 2 | 0 |
| 30 Jun 18 | 1 | -3 | 2 | 0 |
| 31 Mar 18 | 1 | -3 | 2 | 0 |
| 31 Dec 17 | 2 | -4 | 2 | 0 |
| 30 Sep 17 | 2 | -4 | 4 | 0 |
| 30 Jun 17 | 2 | -3 | 3 | 0 |
| 31 Mar 17 | 1 | -3 | 3 | 0 |
| 31 Dec 16 | 1 | -2 | 3 | 0 |
| 30 Sep 16 | 1 | -2 | 2 | 0 |
| 30 Jun 16 | 1 | -1 | 2 | 0 |
| 31 Mar 16 | 1 | -4 | 4 | 0 |
| 31 Dec 15 | 1 | -4 | 4 | 0 |
| 30 Sep 15 | 2 | -16 | 16 | 0 |
| 30 Jun 15 | 2 | -16 | 16 | 0 |
| 31 Mar 15 | 1 | -13 | 13 | 0 |
| 31 Dec 14 | 1 | -13 | 13 | 0 |
| 30 Sep 14 | 0 | -10 | 11 | 0 |
| 30 Jun 14 | 0 | -11 | 11 | 0 |
| 31 Mar 14 | 0 | -11 | 11 | 0 |
| 31 Dec 13 | 0 | -11 | 11 | 0 |
| 30 Sep 13 | 0 | -1 | 0 | 0 |
Quality Earnings: CDIX has a high level of non-cash earnings.
Growing Profit Margin: CDIX became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CDIX has become profitable over the past 5 years, growing earnings by 42.8% per year.
Accelerating Growth: CDIX has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CDIX has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (14.9%).
Return on Equity
High ROE: Whilst CDIX's Return on Equity (40.18%) is outstanding, this metric is skewed due to their high level of debt.